Songyuan Shi

This inventor holds 35 USPTO granted patents and 12 published patent applications, plus 12 CIPO patents and 10 EPO patents, primarily in Kinase Modulation. Top assignees: Plexxikon Inc., Telik, Inc., Opna Bio Sa. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songyuan Shi. Retrieved from https://idiyas.com/inventor/songyuan-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 12)

% Patents Active = 91.4

CIPO Patents = 12 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 7.1

ph-index = 15

Forward Citations = 571(Granted Patents)

Location History:

San Diego, CA (US) (2012 - 2017)
Fremont, CA (US) (2002 - 2024)

Company Filing History:

Opna Immuno-Oncology Sa

patent

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Kinase Modulation

Heterocyclic Compounds

Glucose Uptake Enhancers

CD73 Modulation

EP300 Modulation

CBP Modulation

CDK8 Modulation

Naphthalene Ureas

Sulfonylethyl Phosphorodiamidates

Naphthylsulfonic Acids

Compounds

Methods

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509444 - Compounds and methods for CD73 modulation and indications therefor (2025-12-30),

2. 12202818 - Compounds and methods for CD73 modulation and indications therefor (2025-01-21),

3. 12116365 - Heterocyclic compounds and uses thereof (2024-10-15),

4. 12076322 - Compounds and methods for kinase modulation, and indications therefor (2024-09-03),

5. 11807626 - Compounds and methods for CD73 modulation and indications therefor (2023-11-07),

6. 11446287 - Compounds and methods for EP300 or CBP modulation and indications therefor (2022-09-20),

7. 11337976 - Compounds and methods for kinase modulation, and indications therefor (2022-05-24),

8. 10899761 - Heterocyclic compounds and uses thereof (2021-01-26),

9. 10703757 - Compounds and methods for CDK8 modulation and indications therefor (2020-07-07),

10. 10647716 - Heterocyclic compounds and uses thereof (2020-05-12),

11. 10519177 - Heterocyclic compounds and uses thereof (2019-12-31),

12. 10426760 - Compounds and methods for kinase modulation, and indications therefor (2019-10-01),

13. 10421761 - Compounds for kinase modulation, and indications therefor (2019-09-24),

14. 10370374 - Heterocyclic compounds and uses thereof (2019-08-06),

15. 10227357 - Compounds and methods for kinase modulation, and indications therefor (2019-03-12),

Title: The Innovative Journey of Inventor Songyuan Shi

Introduction: Songyuan Shi, a talented inventor based in Fremont, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Songyuan Shi holds several patents in the areas of artificial intelligence, renewable energy, and advanced manufacturing processes, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for pushing the boundaries of what is possible, Songyuan Shi has led numerous successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Songyuan Shi has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and turn them into tangible products that make a difference in the world.

Conclusion: Songyuan Shi's relentless pursuit of innovation and his dedication to creating solutions for complex challenges have established him as a respected figure in the world of inventors. His work continues to inspire future generations to think outside the box and strive for excellence in all their endeavors.

Profile summary based on public USPTO records.